Artwork

Content provided by optimalhealthweekly. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by optimalhealthweekly or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Viral Social Media 'Ice Bucket Challenge' help fund a new ALS treatment, but experts have varying opinions about its approval

21:20
 
Share
 

Manage episode 345746529 series 3320312
Content provided by optimalhealthweekly. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by optimalhealthweekly or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode of Optimal Health Weekly we discuss the Ice Bucket Challenge funding research for ALS. ALS or or Lou Gehrig’s disease is a nervous system disease that impacts nerve cells that control our voluntary muscle movement. For most patients, symptoms do get worse over time, resulting in respiratory failure.

Remember the “Ice Bucket Challenge” in 2015? People around the world were dropping buckets full of ice water on their heads and donating money to support the good cause. The IceBucket challenge was started by people with amyotrophic lateral sclerosis disease to help raise awareness for the condition.

The viral social media trend also raised $215 million dollars in donations. The ALS association invested some of the donation money into developing and trialling a new therapy for ALS. This year, the Food and Drug Administration approved stem cell therapy clinical trials to treat ALS.

Stem cells along with Biologic ALS treatments, can add nearly eighteen months onto patients’ lives. Risk for the first hospitalization was measured at a 54% decrease in those receiving the therapy. These were very significant markers of disease progression. While people living with ALS are excited about the approval, some experts believe it was green lit too soon and without scrutiny.

Links mentioned in show:

Previous shows:

1- Weekly Wellness Talk Ep 1

2 - Risks and Benefits of Intermittent Fasting

3- Confronting Alzheimer's

4 - Prevent and treat heart disease

5 - Chronic Liver Disease

6 - Lung Injuries Associated with Vaping

7 - Crohn's and Ulcerative Colitis

8 - Kidney Failure & IgA Nephropathy

9 - Brain Injuries

10 - Stroke

11 - Spinal Injury

12 - Lyme Disease

13 - Autoimmune Disease

14 - Diabetes

15 - Parkinsons

  continue reading

20 episodes

Artwork
iconShare
 
Manage episode 345746529 series 3320312
Content provided by optimalhealthweekly. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by optimalhealthweekly or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode of Optimal Health Weekly we discuss the Ice Bucket Challenge funding research for ALS. ALS or or Lou Gehrig’s disease is a nervous system disease that impacts nerve cells that control our voluntary muscle movement. For most patients, symptoms do get worse over time, resulting in respiratory failure.

Remember the “Ice Bucket Challenge” in 2015? People around the world were dropping buckets full of ice water on their heads and donating money to support the good cause. The IceBucket challenge was started by people with amyotrophic lateral sclerosis disease to help raise awareness for the condition.

The viral social media trend also raised $215 million dollars in donations. The ALS association invested some of the donation money into developing and trialling a new therapy for ALS. This year, the Food and Drug Administration approved stem cell therapy clinical trials to treat ALS.

Stem cells along with Biologic ALS treatments, can add nearly eighteen months onto patients’ lives. Risk for the first hospitalization was measured at a 54% decrease in those receiving the therapy. These were very significant markers of disease progression. While people living with ALS are excited about the approval, some experts believe it was green lit too soon and without scrutiny.

Links mentioned in show:

Previous shows:

1- Weekly Wellness Talk Ep 1

2 - Risks and Benefits of Intermittent Fasting

3- Confronting Alzheimer's

4 - Prevent and treat heart disease

5 - Chronic Liver Disease

6 - Lung Injuries Associated with Vaping

7 - Crohn's and Ulcerative Colitis

8 - Kidney Failure & IgA Nephropathy

9 - Brain Injuries

10 - Stroke

11 - Spinal Injury

12 - Lyme Disease

13 - Autoimmune Disease

14 - Diabetes

15 - Parkinsons

  continue reading

20 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide